{"id":"W2300207219","doi":"10.1634/theoncologist.2016-0069","title":"Enhanced Cardiac Testing in a Dual Anti-HER2 Regimen: What Have We Learned?","year":2016,"lang":"en","type":"letter","venue":"The Oncologist","topic":"Chemotherapy-induced cardiotoxicity and mitigation","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"ca_institutions":"Institute of Cancer Research","funders":"","keywords":"Medicine; Cardiotoxicity; Dexrazoxane; Trastuzumab; Anthracycline; Cardioprotection; Oncology; Doxorubicin; Regimen; Internal medicine; Pharmacology; Adverse effect; Clinical trial; Cardiology; Chemotherapy; Cancer; Myocardial infarction; Breast cancer","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0009036819,0.000409552,0.001019043,0.000142651,0.0001304195,0.0001008868,0.0002024615,0.001142676,0.00007951151],"category_scores_gemma":[0.0004094011,0.0002602451,0.0003089891,0.0002426166,0.00044087,0.0001674451,0.00009339325,0.002166328,0.000140821],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.000733954,"about_ca_system_score_gemma":0.0004127653,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0001639247,"about_ca_topic_score_gemma":0.00002671701,"domain_scores_codex":[0.9974603,0.0003898339,0.0004417927,0.0006006741,0.0004823185,0.0006250484],"domain_scores_gemma":[0.9976844,0.0009860233,0.0003313886,0.0008064414,0.0001284941,0.00006330005],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","study_design_scores_codex":[0.0001660773,0.00007002582,0.0001591928,0.0003093159,0.0003056221,0.001202996,0.001332778,0.000006217957,0.2406972,0.00001742979,0.5938072,0.1619259],"study_design_scores_gemma":[0.001988087,0.0004949103,0.0004541179,0.002582797,0.0002241218,0.000183157,0.0008536784,0.000008021395,0.1028971,0.000440042,0.8893846,0.0004893612],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","genre_codex":"commentary","genre_gemma":"commentary","genre_scores_codex":[0.04211655,0.001698314,0.00007300255,0.9270547,0.001204376,0.001482339,0.00002258622,0.0001790691,0.02616908],"genre_scores_gemma":[0.2483281,0.007032334,0.0004112037,0.678217,0.02522023,0.0003930954,0.0002398151,0.0002338723,0.03992439],"genre_candidate":"commentary","genre_consensus":"commentary","teacher_disagreement_score":0.2955774,"threshold_uncertainty_score":0.999985,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.06247023935942844,"score_gpt":0.3184028482091724,"score_spread":0.255932608849744,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}